Sharpe ratio
0.90Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+20.62%1Y Absolute Return
-0.21%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| quant Healthcare Fund - Growth Option - Direct PlanFund 3Y annualised return · 5Y history unavailable | ₹12,63,781 | ₹7,32,612 | ₹5,31,169 | +21.39% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.22
₹1 Lakh since launch₹1.22 Lakh
Fund age3.3 yrs
Fund information
Scheme code151853
ISININF966L01CD0
BenchmarkNIFTY Healthcare TRI.
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio1.51%
Exit loadExit load of 1%, if redeemed within 15 days.
Minimum SIP₹1,000 SIP
Return comparison
54th / 932 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +95.89% | — | — |
| 3M | +15.80% | — | — |
| 6M | +31.15% | — | — |
| 1Y | +20.62% | — | +4.16% |
| 3Y | +21.39% | — | +12.54% |
| Since Launch | +22.02% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.28Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
16.45%How much the fund’s returns fluctuate over time.
High volatility
Returns can swing significantly.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
0.87How well the fund rewarded investors relative to its biggest decline.
Good
Good return relative to the drawdowns experienced.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 25 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Repo | Unspecified | Repo | 11.5922% |
| Divi's Laboratories Ltd. 25.08.2026 | Healthcare | Futures | 9.9345% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 9.9328% |
| Concord Biotech Ltd. | Healthcare | Equity | 9.657% |
| Zydus Wellness Ltd | Consumer Staples | Equity | 9.3323% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 9.2466% |
| Glenmark Pharmaceuticals Ltd. 25.08.2026 | Healthcare | Futures | 9.2071% |
| HFCL Ltd | Technology | Equity | 7.8936% |
| SMS Pharmaceuticals Ltd | Healthcare | Equity | 7.2749% |
| Glenmark Life Sciences Ltd | Healthcare | Equity | 7.1939% |
Fund management
VA
Varun Pattani
Since 2025 · Prior to joining Quant Mutual Fund, he has worked with boutique PMS firm.
Mr. Pattani is an ACA
AY
Ayusha Kumbhat
Since 2025 · She is working with Quant Mutual fund as Research Analyst for the past 15 months, specializing in investment research.
CFA Level III, BSc (Hons) in Economics, MSc in Behavioural & Experimental Economics
SA
Sameer Kate
Since 2025 · Prior to joining Quant Mutual Fund, he was working with Investec Capital and Kotak Securities,
Bachelor of Computer Science, MBA from IME Pune.
SA
Sanjeev Sharma
Since 2023 · He has total work experience of 17 years including 13 years of experience in the financial market. He specializes in identifying crucial inflexion points in securities.
Mr. Sharma is a Commerce Graduate and PGDBA (Finance) from Symbiosis, Pune.
SA
Sandeep Tandon
Since 2023 · Prior to joining Quant Mutual Fund, he has worked with ICICI Securities as Vice President, The Economic Times and IDBI AMC.
Mr. Tandon has done MBA (Finance)
AN
Ankit A Pande
Since 2023 · Prior to joining Quant Mutual Fund he has worked with Infosys Finacle. Began his career in equity research in 2011.
Mr. Pande has done CFA and MBA
YU
Yug Tibrewal
Since 2025 · Yug is an investment professional with over 2 years of experience in dealing related activities
B.M.S, CFA L1
Compare similar funds
No comparable category funds are available yet.
Summary
A very high-risk equity scheme - sectoral/ thematic fund. Ahead of its category average over 3Y by 8.9 points. Top 10 holdings make up 77% — a handful of stocks can swing returns sharply.
Strengths
- Ahead of its category average over 3Y by 8.9 points.
- Ranks 54 of 932 in its category over 1 year.
Weaknesses
- Top 10 holdings make up 77% — a handful of stocks can swing returns sharply.
Ideal investor
- Needs a 5–7+ years horizon to ride out its very high risk level.
- Good fit for SIPs — spreading purchases smooths out 16.4% volatility.
Risk drivers
- Top 10 holdings = 77% of the portfolio.
- Healthcare makes up 82% — trouble in that sector hits the whole fund.